Cargando…

Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience

BACKGROUND: Primary sclerosing cholangitis (PSC) is a progressive cholestatic liver disease, with liver transplantation being the sole life-saving treatment for end-stage PSC-related liver disease. However, recurrence of PSC after liver transplantation is a common complication, with the risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueda, Yoshihide, Kaido, Toshimi, Okajima, Hideaki, Hata, Koichiro, Anazawa, Takayuki, Yoshizawa, Atsushi, Yagi, Shintaro, Taura, Kojiro, Masui, Toshihiko, Yamashiki, Noriyo, Haga, Hironori, Nagao, Miki, Marusawa, Hiroyuki, Seno, Hiroshi, Uemoto, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Liver Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828688/ https://www.ncbi.nlm.nih.gov/pubmed/29536035 http://dx.doi.org/10.1097/TXD.0000000000000751

Ejemplares similares

Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study
por: Ueda, Daisuke, et al.
Publicado: (2018)

Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
por: Tajima, Tetsuya, et al.
Publicado: (2019)

Longitudinal Analysis of the Intestinal Microbiota in Liver Transplantation
por: Kato, Karin, et al.
Publicado: (2017)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
por: Yamada, Yohei, et al.
Publicado: (2018)

The Impact of Biliary Reconstruction Methods on Small Partial Liver Grafts
por: Yoshikawa, Junichi, et al.
Publicado: (2020)

Sclerosing encapsulating peritonitis after living-donor liver transplantation: A case series, Kyoto experience
por: Aliyev, Vusal, et al.
Publicado: (2018)

Liver Transplantation for Recurrent Cholangitis From Von Meyenburg Complexes
por: Panda, Nikhil, et al.
Publicado: (2019)

Living donor liver transplantation for adult Budd Chiari syndrome – Resection without replacement of retrohepatic IVC: A case report
por: Sabra, Tarek Abdelazeem, et al.
Publicado: (2017)

Mass-forming intrahepatic cholangiocarcinoma with portal vein tumor thrombus and bile duct tumor thrombus: A case report
por: Iwaki, Kentaro, et al.
Publicado: (2017)

Living Donor Liver Transplantation Using a Liver Graft With Congenital Intrahepatic Portosystemic Shunt
por: Kamei, Hideya, et al.
Publicado: (2015)

IgG4-related sclerosing cholangitis: liver biopsy findings
por: Ryu, Han Suk, et al.
Publicado: (2011)

Spontaneous clearance of hepatitis C virus after liver transplantation: a report of four cases
por: Tamaki, Ichiro, et al.
Publicado: (2015)

Effects of Adding Congested Segment IV to the Left Lateral Graft on Short-term Outcomes in Pediatric Living-donor Liver-transplant Recipients
por: Aoki, Hikaru, et al.
Publicado: (2023)

Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide Survey
por: Eguchi, Susumu, et al.
Publicado: (2016)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022)

Adult Living Donor Liver Transplantation for Patients With Portal Vein Thrombosis: A Single-center Experience
por: Miura, Kohei, et al.
Publicado: (2018)

CT With Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
por: Ohki, Takamasa, et al.
Publicado: (2013)

Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
por: Ueda, Yoshihide, et al.
Publicado: (2013)

Correction: Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
por: Ueda, Yoshihide, et al.
Publicado: (2013)

Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis
por: Yoshida, Hiroyuki, et al.
Publicado: (2023)

The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation
por: Tada, Seiichiro, et al.
Publicado: (2020)

Identification of Novel and Noninvasive Biomarkers of Acute Cellular Rejection After Liver Transplantation by Protein Microarray
por: Okubo, Keita, et al.
Publicado: (2016)

The Kupffer Cell Number Affects the Outcome of Living Donor Liver Transplantation from Elderly Donors
por: Hidaka, Masaaki, et al.
Publicado: (2016)

Normothermic Machine Perfusion of Deceased Donor Liver Grafts Is Associated With Improved Postreperfusion Hemodynamics
por: Angelico, Roberta, et al.
Publicado: (2016)

Reluctance to Accept Alcohol Treatment by Alcoholic Liver Disease Transplant Patients: A Qualitative Study
por: Heyes, Cathy M., et al.
Publicado: (2016)

Liberation From Renal Replacement Therapy After Cadaveric Liver Transplantation
por: Hilmi, Ibtesam A., et al.
Publicado: (2016)

Ethylene Glycol Poisoning Should Not Contraindicate Liver Donation
por: Burman, Alisha, et al.
Publicado: (2017)

Avoiding ICU Admission by Using a Fast-Track Protocol Is Safe in Selected Adult-to-Adult Live Donor Liver Transplant Recipients
por: Echeverri, Juan, et al.
Publicado: (2017)

Adapting the Surgical Apgar Score for Perioperative Outcome Prediction in Liver Transplantation: A Retrospective Study
por: Pearson, Amy C. S., et al.
Publicado: (2017)

Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience
por: Benkö, Tamas, et al.
Publicado: (2017)

A Formula to Calculate Standard Liver Volume Using Thoracoabdominal Circumference
por: Shaw, Brian I., et al.
Publicado: (2017)

The Implications of the Shift Toward Donation After Circulatory Death in Australia
por: Reiling, Janske, et al.
Publicado: (2017)

Transplantation of a Liver Allograft From a Hepatitis C Virus Seropositive Donor With Previous Sustained Virologic Response to an Uninfected Recipient Suffering Steroid Refractory Acute Graft Rejection With No Evidence of HCV Transmission
por: Mitchell, Robert A., et al.
Publicado: (2018)

Cardiac MRI T2* in Liver Transplant Candidates: Application and Performance of a Novel Imaging Technique to Identify Patients at Risk for Poor Posttransplant Cardiac Outcomes
por: Lewin, Sara M., et al.
Publicado: (2018)

Liver Allograft Failure After Nivolumab Treatment—A Case Report With Systematic Literature Research
por: Gassmann, Dimitri, et al.
Publicado: (2018)

Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients
por: Engels, Eric A., et al.
Publicado: (2018)

The Impact of Implantation Time During Liver Transplantation on Outcome: A Eurotransplant Cohort Study
por: Jochmans, Ina, et al.
Publicado: (2018)

Accessory Gallbladder Complicating Liver Transplantation
por: Kesseli, Samuel J., et al.
Publicado: (2018)

Role of MRCP in Diagnosing Biliary Anastomotic Strictures After Liver Transplantation: A Single Tertiary Care Center Experience
por: Akbar, Ali, et al.
Publicado: (2018)

Liver Transplantation Without Venovenous Bypass: Does Surgical Approach Matter?
por: Barbas, Andrew S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_70j7vbc85kl4djofs5mc3ctrg1